Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry

Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Purchased by Ziegler Capital Management LLC

Defense World ·  {{timeTz}}

Ziegler Capital Management LLC boosted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Rating) by 38.4% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 19,417 shares of the medical equipment provider's stock after purchasing an additional 5,390 shares during the quarter. Ziegler Capital Management LLC's holdings in Intuitive Surgical were worth $3,897,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently added to or reduced their stakes in ISRG. GAM Holding AG increased its stake in Intuitive Surgical by 18.4% during the second quarter. GAM Holding AG now owns 135,915 shares of the medical equipment provider's stock worth $28,506,000 after acquiring an additional 21,122 shares during the last quarter. Charter Oak Capital Management LLC acquired a new stake in Intuitive Surgical during the second quarter worth about $88,000. Beacon Investment Advisory Services Inc. increased its stake in Intuitive Surgical by 64.0% during the second quarter. Beacon Investment Advisory Services Inc. now owns 6,399 shares of the medical equipment provider's stock worth $1,284,000 after acquiring an additional 2,498 shares during the last quarter. Derbend Asset Management increased its stake in Intuitive Surgical by 16.0% during the second quarter. Derbend Asset Management now owns 7,220 shares of the medical equipment provider's stock worth $1,449,000 after acquiring an additional 995 shares during the last quarter. Finally, Hollencrest Capital Management increased its stake in Intuitive Surgical by 1.0% during the second quarter. Hollencrest Capital Management now owns 5,234 shares of the medical equipment provider's stock worth $1,051,000 after acquiring an additional 50 shares during the last quarter. 82.44% of the stock is currently owned by institutional investors and hedge funds.

Get Intuitive Surgical alerts:

Insiders Place Their Bets

In other Intuitive Surgical news, Director Amal M. Johnson sold 6,375 shares of the stock in a transaction that occurred on Wednesday, August 3rd. The stock was sold at an average price of $238.04, for a total transaction of $1,517,505.00. Following the transaction, the director now owns 11,224 shares of the company's stock, valued at approximately $2,671,760.96. The transaction was disclosed in a document filed with the SEC, which is available at this link. In other news, EVP Myriam Curet sold 9,000 shares of the stock in a transaction that occurred on Wednesday, July 27th. The stock was sold at an average price of $225.00, for a total transaction of $2,025,000.00. Following the sale, the executive vice president now directly owns 217 shares in the company, valued at approximately $48,825. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Amal M. Johnson sold 6,375 shares of the stock in a transaction that occurred on Wednesday, August 3rd. The stock was sold at an average price of $238.04, for a total value of $1,517,505.00. Following the sale, the director now owns 11,224 shares in the company, valued at $2,671,760.96. The disclosure for this sale can be found here. Insiders have sold a total of 101,162 shares of company stock valued at $22,062,916 in the last quarter. Insiders own 0.90% of the company's stock.

Intuitive Surgical Stock Down 0.9 %

NASDAQ:ISRG opened at $187.44 on Monday. The business's 50 day moving average is $216.24 and its two-hundred day moving average is $229.56. Intuitive Surgical, Inc. has a 52 week low of $184.94 and a 52 week high of $369.69. The company has a market cap of $66.94 billion, a PE ratio of 47.69, a P/E/G ratio of 5.26 and a beta of 1.31.

Intuitive Surgical (NASDAQ:ISRG – Get Rating) last released its earnings results on Thursday, July 21st. The medical equipment provider reported $0.85 EPS for the quarter, missing analysts' consensus estimates of $1.04 by ($0.19). Intuitive Surgical had a return on equity of 12.04% and a net margin of 24.05%. The firm had revenue of $1.52 billion for the quarter, compared to the consensus estimate of $1.56 billion. During the same period in the prior year, the business earned $1.42 EPS. As a group, sell-side analysts expect that Intuitive Surgical, Inc. will post 3.76 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the company. Raymond James dropped their price target on Intuitive Surgical from $294.00 to $255.00 in a research note on Friday, July 22nd. Deutsche Bank Aktiengesellschaft lowered their target price on Intuitive Surgical from $225.00 to $205.00 in a research note on Friday, July 22nd. Stifel Nicolaus increased their target price on Intuitive Surgical from $250.00 to $260.00 and gave the company a "buy" rating in a research note on Friday, September 9th. BTIG Research lowered their target price on Intuitive Surgical from $355.00 to $247.00 and set a "buy" rating for the company in a research note on Monday, July 18th. Finally, The Goldman Sachs Group lowered their target price on Intuitive Surgical from $319.00 to $273.00 and set a "buy" rating for the company in a research note on Friday, July 29th. Six analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Intuitive Surgical has a consensus rating of "Moderate Buy" and a consensus target price of $268.00.

Intuitive Surgical Company Profile

(Get Rating)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

See Also

  • Get a free copy of the StockNews.com research report on Intuitive Surgical (ISRG)
  • Archer Daniels Midland: Dividend Hero With 49 Years Of Increases
  • Will Fully Autonomous Tractors Make Deere the Tesla of Farming?
  • Magna International is Your Auto and EV One-Stop Shop Stock
  • EV Battery Maker Freyr Set For Major Global Expansion
  • MarketBeat: Week in Review 9/26 – 9/30

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Rating).

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

This presentation is for informational and educational use only and is not a recommendation or endorsement of any particular investment or investment strategy. Investment information provided in this content is general in nature, strictly for illustrative purposes, and may not be appropriate for all investors. It is provided without respect to individual investors’ financial sophistication, financial situation, investment objectives, investing time horizon, or risk tolerance. You should consider the appropriateness of this information having regard to your relevant personal circumstances before making any investment decisions. Past investment performance does not indicate or guarantee future success. Returns will vary, and all investments carry risks, including loss of principal. Moomoo makes no representation or warranty as to its adequacy, completeness, accuracy or timeliness for any particular purpose of the above content.

Moomoo is a financial information and trading app offered by Moomoo Technologies Inc.
In the U.S., investment products and services available through the moomoo app are offered by Moomoo Financial Inc., a broker-dealer registered with the U.S. Securities and Exchange Commission (SEC) and a member of Financial Industry Regulatory Authority (FINRA)/Securities Investor Protection Corporation (SIPC).
In Singapore, investment products and services available through the moomoo app are offered through Moomoo Financial Singapore Pte. Ltd. regulated by the Monetary Authority of Singapore (MAS). Moomoo Financial Singapore Pte. Ltd. is a Capital Markets Services Licence (License No. CMS101000) holder with the Exempt Financial Adviser Status. This advertisement has not been reviewed by the Monetary Authority of Singapore.
In Australia, financial products and services available through the moomoo app are provided by Futu Securities (Australia) Ltd, an Australian Financial Services Licensee (AFSL No. 224663) regulated by the Australian Securities and Investment Commission (ASIC). Please read and understand our Financial Services Guide, Terms and Conditions, Privacy Policy and other disclosure documents which are available on our websites https://www.futuau.com and https://www.moomoo.com/au. Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd. and Futu Securities (Australia) Ltd are affiliated companies.